CXCL13 and Lyme disease: We set the target, especially for clinicians, to elaborate on the role of CSF-CXCL13 as a differential diagnostic biomarker of neuroborreliosis, an activity marker of autoimmune CNS diseases and a possible severity marker in neurological infectious CNS diseases.